Article Text

PDF

Colorectal
PWE-089 The roles of CYP2C40 and CYP2C55 in preventing colon cancer
  1. M Albert1,
  2. A Bennett2
  1. 1School of Medicine, University of Nottingham, Nottingham, UK
  2. 2School of Biomedical Sciences, University of Nottingham, Nottingham, UK

Abstract

Introduction Certain Cytochrome P450 (CYP)-dependent arachidonic acid (AA) metabolites are thought to induce therapeutic effects in the colon via activation of peroxisome proliferator activated receptors (PPARs), specifically the PPAR α subtype. The activation of PPAR α leads to changes in the expression and activity of target genes and other transcription factors such as COX-2, NF-KB and AP-1, resulting in anti-inflammatory and anti-tumorigenic effects. CYP2C40 and CYP2C55 are two recently discovered CYPs, isolated from the murine intestinal tract. Their metabolites include 16-HETE, 8,9-EET and 14,15-EET which have been shown to have anti-inflammatory effects both in vitro and in vivo. Evidence suggests that CYP2C40 and CYP2C55 may have a potential therapeutic role to play in colon tumorigenesis. This study aims to determine whether PPAR activation leads to an up-regulation in the expression of CYP2C40 and CYP2C55.

Methods CYP2C40 and CYP2C55 promoter regions were isolated from murine DNA via PCR and inserted into a luciferase plasmid (pGL4.10). Plasmid DNA was cloned following transfection into highly competent cells and purified via Midi-Prep recovery. Purified plasmids were transfected into COS-7 and HCA-7 cells and the cells were treated with PPAR α, β and γ ligands Wy14643, GW0742 and Rosiglitazone (COS-7 cells had PPAR α/β/γ over-expressed). Cells were harvested after 24 h incubation and luciferase activity (equivalent to gene expression) was measured in relative light units (RLU) using a reporter assay system.

Results In COS-7 cells PPAR α, β and γ ligands led to a significant increase in CYP2C40 RLU from a baseline measurement of (mean (±SD)) 235 (20) to 726 (45), 458 (61) and 466 (42) for PPAR α, β and γ respectively. CYP2C55 showed a significant increase from 154 (6) to 263 (10) and 354 (21) for PPAR α and β respectively (p=0.001). HCA-7 cells were shown to only express endogenous PPAR α and following incubation with PPAR α, β and γ ligands a significant RLU increase was observed in CYP2C40 from 55 (13) to 126 (17) and in CYP2C55 from 62 (11) to 111 (4) for PPAR α (p=0.001).

Conclusion The results suggest that a functional peroxisome proliferator response element (PPRE) exists within the promoter regions of CYP2C40 and CYP2C55 and that activation of PPAR α within the HCA-7 cell line leads to a significant increase in CYP2C40 and CYP2C55 expression. Given the beneficial properties of PPAR α and CYP derived AA metabolites it seems that CYP2C40 and CYP2C55 may become important future therapeutic targets in colon cancer.

Competing interests None declared.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.